AU3194089A - Method for protection from chemotherapeutic side effects - Google Patents

Method for protection from chemotherapeutic side effects

Info

Publication number
AU3194089A
AU3194089A AU31940/89A AU3194089A AU3194089A AU 3194089 A AU3194089 A AU 3194089A AU 31940/89 A AU31940/89 A AU 31940/89A AU 3194089 A AU3194089 A AU 3194089A AU 3194089 A AU3194089 A AU 3194089A
Authority
AU
Australia
Prior art keywords
protection
side effects
chemotherapeutic side
chemotherapeutic
effects
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU31940/89A
Other versions
AU636107B2 (en
Inventor
Philip S. Schein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MedImmune LLC
Original Assignee
MedImmune LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MedImmune LLC filed Critical MedImmune LLC
Publication of AU3194089A publication Critical patent/AU3194089A/en
Application granted granted Critical
Publication of AU636107B2 publication Critical patent/AU636107B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU31940/89A 1988-02-23 1989-02-21 Method for protection from chemotherapeutic side effects Expired AU636107B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15910488A 1988-02-23 1988-02-23
US159104 1988-02-23

Publications (2)

Publication Number Publication Date
AU3194089A true AU3194089A (en) 1989-09-22
AU636107B2 AU636107B2 (en) 1993-04-22

Family

ID=22571099

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31940/89A Expired AU636107B2 (en) 1988-02-23 1989-02-21 Method for protection from chemotherapeutic side effects

Country Status (5)

Country Link
EP (1) EP0409845A4 (en)
JP (1) JPH03503888A (en)
AU (1) AU636107B2 (en)
CA (1) CA1336506C (en)
WO (1) WO1989007942A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU627207B2 (en) * 1988-08-18 1992-08-20 Boehringer Mannheim Gmbh Pharmaceutical composition comprising protein kinase c inhibitor and anti-cancer agent

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567686A (en) * 1992-03-13 1996-10-22 Arch Development Corporation Method for protection against genotoxic mutagenesis
US6051563A (en) * 1997-02-12 2000-04-18 U.S. Bioscience, Inc. Methods for the administration of amifostine and related compounds
US6573253B2 (en) 1997-02-12 2003-06-03 Medimmune Oncology Inc. Methods for the administration of amifostine and related compounds
US6239119B1 (en) 1998-04-27 2001-05-29 Medimmune Oncology, Inc. Topical administration of amifostine and related compounds
US6489312B1 (en) 1999-06-15 2002-12-03 Medimmune Oncology, Inc. Pharmaceutical formulations comprising aminoalkyl phosphorothioates
US7053072B2 (en) 2001-05-11 2006-05-30 Medimmune Oncology, Inc. Methods for the administration of amifostine and related compounds
CN102260288B (en) * 2010-06-08 2014-02-26 成都大有得药业有限公司 Synthesis method of 3-amino-propyl aminoethyl thiophosphate trihydrate
RU2450791C1 (en) * 2010-10-18 2012-05-20 Федеральное государственное учреждение "Ростовский научно-исследовательский онкологический институт Федерального агентства по высокотехнологичной медицинской помощи" Method for determining cardiotoxic complications in patients with chronic lymphatic leukemia
CN104230984B (en) * 2013-06-08 2017-02-08 国药集团国瑞药业有限公司 Preparation method for trihydrate 3-amino propyl aminoethyl thiophosphoric acid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656034A (en) * 1985-05-20 1987-04-07 Survival Technology, Inc. Absorption enhancing agents

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU627207B2 (en) * 1988-08-18 1992-08-20 Boehringer Mannheim Gmbh Pharmaceutical composition comprising protein kinase c inhibitor and anti-cancer agent

Also Published As

Publication number Publication date
WO1989007942A1 (en) 1989-09-08
JPH03503888A (en) 1991-08-29
EP0409845A1 (en) 1991-01-30
AU636107B2 (en) 1993-04-22
CA1336506C (en) 1995-08-01
EP0409845A4 (en) 1991-07-03

Similar Documents

Publication Publication Date Title
AU3425089A (en) Brainwave-responsive apparatus
AU4877690A (en) Fire-stopping apparatus
AU3151689A (en) Improved cryo-slammer
AU2561088A (en) Line protecting apparatus
AU3810989A (en) Compounds
AU618828B2 (en) Course-correction system for course-correctable objects
AU7947991A (en) Compounds
AU2864489A (en) 16-dehydro-vitamin d3-derivatives
AU3301689A (en) 1-azabicyclo-alkyl derivatives
AU4218589A (en) Separator
AU3542489A (en) Separator
AU3194089A (en) Method for protection from chemotherapeutic side effects
AU4169089A (en) (Diarylmethoxy)-1-pyrrolidines and-piperidines
AU2963389A (en) Pyranobenzoxadiazole derivatives
AU616039B2 (en) Benzopyranol derivatives
AU3315889A (en) Phosphonoalkylpurine derivatives
AU3330789A (en) Arylpropanamine derivatives
AU4215989A (en) Protection arrangement for rotator units
AU3156989A (en) Androst-4-ene derivatives
AU3301589A (en) Oxadiazole-1-azabicyclo-alkane derivatives
AU1785588A (en) Ferrohydrostatic separator
AU3289989A (en) Interceptors
AU3526789A (en) Sulphonylaminoguanidinoazine compounds
AU4463989A (en) Pyranylethyl-naphthalene derivatives
AU2508688A (en) Yacht-hull